Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and is associated with various clinicopathological characteristics such as genetic mutations and viral infections. Therefore, numerous laboratories look out for identifying always new putative markers for the improvement of HCC diagnosis/prognosis. Many molecular profiling studies investigated gene expression changes related to HCC.